-
Costs for CF Therapies Are Going Up in 2019
Costs for approved cystic fibrosis (CF) treatments and new approvals — including therapies extended to more age groups or targeting new mutations — could double in price in 2019, according to pharmacy benefit manager Prime Therapeutics. Click here to find out more.
How do you feel about this prediction? Are you prepared to pay more for your treatments?
Sorry, there were no replies found.
Log in to reply.